Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Penicillin Challenge in Low Risk Hospitalized Patients
NCT04408508Unknown
- Sponsor
- Saskatchewan Health Authority
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of amoxicillin in penicillin allergy, sponsored by Saskatchewan Health Authority. Primary endpoint: Number of patients tolerating oral amoxicillin challenge at 12 months. Status: unknown.
02
Drugs
amoxicillin
03
Conditions
penicillin allergy
Beyond the preview
Go deeper on NCT04408508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408508.